?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
496 Unternehmen gefunden • Seite 2 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Nhu Co Ltd | 79.2 | Arzneimittel (Pharmazeutisch) | China | 11.7 Mrd. USD | 10.69 | - | 3.15 | 2.14 | ▲ 16.62% | ▲ 13.67% | 3.94% | ▲ 10.48% | 1 Jahre | 30.40% | ▲ 0.68% | 35.85% | ▲ 0.83% | 31.00% | ▲ 5.92% | 8 / 9 | 7,48 | 23-fach | 22 / 100 | −4,5 / 100 | −2,76 | |
![]() | Exelixis Inc | 79.1 | Arzneimittel (Biotechnologie) | USA | 16.4 Mrd. USD | 19.06 | 14.16 | 6.73 | 8.90 | ▲ 18.63% | ▲ 47.58% | - | - | - | 33.73% | ▲ 4.80% | 37.59% | ▲ 5.06% | 36.39% | ▲ 4.12% | 7 / 9 | 7,85 | unbegrenzt | 79 / 100 | −3,6 / 100 | −2,59 |
![]() | Novartis AG | 78.9 | Arzneimittel (Pharmazeutisch) | Schweiz | 304.5 Mrd. USD | 30.70 | 20.32 | 5.49 | 8.18 | ▲ 2.74% | ▲ 12.66% | 2.86% | ▲ 4.28% | 29 Jahre | 25.64% | ▼ -5.09% | 31.15% | ▲ 2.64% | 32.27% | ▲ 0.96% | 7 / 9 | 3,22 | 14-fach | 37 / 100 | −4,7 / 100 | −2,55 |
| Zhejiang Jolly Pharmaceutical Co Ltd | 78.1 | Arzneimittel (Pharmazeutisch) | China | 1.3 Mrd. USD | 13.65 | - | 2.57 | 2.65 | ▲ 22.76% | ▲ 48.06% | 5.45% | - | 5 Jahre | 20.78% | ▲ 2.15% | 26.21% | ▲ 2.65% | 4.10% | ▼ -1.25% | 6 / 9 | 5,57 | > 50-fach | 40 / 100 | 4,7 / 100 | −3,19 | |
| PharmaEssentia | 77.8 | Arzneimittel (Pharmazeutisch) | Taiwan | 15.8 Mrd. USD | 67.79 | 87.07 | 24.92 | 14.05 | ▲ 94.81% | - | 0.13% | - | - | 32.27% | ▲ 99.91% | 31.52% | ▲ 101.11% | 21.57% | ▲ 90.33% | 6 / 9 | 11,95 | > 50-fach | 37 / 100 | −0,6 / 100 | −2,09 | |
![]() | ALK-Abelló A/S | 77.7 | Arzneimittel (Pharmazeutisch) | Dänemark | 8.1 Mrd. USD | 39.83 | 29.16 | 7.91 | 7.78 | ▲ 12.58% | ▲ 116.79% | 0.66% | - | - | 18.96% | ▲ 3.40% | 26.35% | ▲ 4.71% | 24.41% | ▲ 5.30% | 8 / 9 | 8,12 | 32-fach | 45 / 100 | −6,8 / 100 | −2,92 |
![]() | Argen-X | 77.4 | Arzneimittel (Biotechnologie) | Niederlande | 57.2 Mrd. USD | 22.23 | 51.18 | 6.98 | - | ▲ 158.22% | - | - | - | - | 32.38% | ▲ 42.91% | 24.82% | ▲ 35.61% | 21.09% | ▲ 54.95% | 6 / 9 | 10,75 | > 50-fach | 43 / 100 | 5,3 / 100 | −1,64 |
![]() | ACADIA Pharmaceuticals Inc | 77.3 | Arzneimittel (Biotechnologie) | USA | 3.5 Mrd. USD | 9.20 | 20.08 | 3.07 | 2.68 | ▲ 19.39% | - | - | - | - | 36.49% | ▲ 20.77% | 9.78% | ▲ 15.73% | 9.81% | ▲ 11.05% | 6 / 9 | 3,94 | unbegrenzt | 63 / 100 | 18,0 / 100 | −0,81 |
| Shanghai Allist Pharmaceuticals Co. Ltd. A | 77.0 | Arzneimittel (Biotechnologie) | China | 5.6 Mrd. USD | 12.89 | - | 5.68 | 4.18 | ▲ 520.80% | - | 1.48% | - | 1 Jahre | 42.18% | ▲ 10.11% | 49.68% | ▲ 12.09% | 41.31% | ▲ 18.71% | 8 / 9 | 15,25 | > 50-fach | 57 / 100 | −2,3 / 100 | −2,07 | |
![]() | Bavarian Nordic | 76.8 | Arzneimittel (Biotechnologie) | Dänemark | 2.8 Mrd. USD | 12.01 | 14.96 | 2.94 | 1.40 | ▲ 27.21% | ▲ 37.73% | - | - | - | 22.29% | ▲ 12.19% | 14.92% | ▲ 7.42% | 22.08% | ▲ 23.49% | 8 / 9 | 12,13 | 27-fach | 20 / 100 | −9,0 / 100 | −3,09 |
| 3SBio Inc | 76.8 | Arzneimittel (Biotechnologie) | China | 4.3 Mrd. USD | 3.50 | 3.18 | 1.62 | 1.05 | ▲ 25.93% | ▲ 58.96% | 1.82% | - | - | 47.93% | ▲ 3.91% | 59.59% | ▲ 6.09% | 51.58% | ▲ 9.66% | 9 / 9 | 12,55 | 33-fach | 49 / 100 | −3,6 / 100 | −2,40 | |
| Tianjin Lisheng Pharmaceutical Co Ltd | 76.6 | Arzneimittel (Pharmazeutisch) | China | 0.6 Mrd. USD | 30.89 | 15.79 | 3.06 | 0.87 | ▲ 4.07% | ▲ 117.40% | 6.70% | ▲ 58.74% | - | 30.04% | ▲ 4.34% | 33.75% | ▲ 4.87% | 29.76% | ▲ 1.70% | 8 / 9 | 10,11 | > 50-fach | 25 / 100 | −0,6 / 100 | −2,88 | |
| Sunshine Guojian Pharmaceutical Shanghai Co Ltd | 76.5 | Arzneimittel (Biotechnologie) | China | 4.3 Mrd. USD | 9.20 | - | 6.43 | 3.32 | ▲ 45.00% | - | 1.46% | - | 1 Jahre | 69.98% | ▲ 18.91% | 78.43% | ▲ 22.26% | 66.45% | ▲ 24.08% | 6 / 9 | 18,28 | > 50-fach | 15 / 100 | 7,1 / 100 | −2,04 | |
![]() | Kiniksa Pharmaceuticals Ltd | 76.3 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 7.7 Mrd. USD | 69.96 | 38.87 | 8.10 | 10.79 | ▲ 144.82% | - | - | - | - | 8.71% | ▲ 74.34% | 11.40% | ▲ 82.03% | 3.75% | ▲ 77.22% | 6 / 9 | 5,18 | unbegrenzt | 48 / 100 | 4,4 / 100 | −2,22 |
![]() | Shionogi & Co. Ltd | 76.2 | Arzneimittel (Pharmazeutisch) | Japan | 14.5 Mrd. USD | 8.68 | 11.33 | 4.05 | 1.30 | ▲ 11.09% | ▲ 13.04% | 2.79% | ▲ 5.14% | - | 41.06% | ▲ 0.95% | 32.30% | ▼ -0.04% | 39.85% | ▲ 3.74% | 6 / 9 | 5,75 | 27-fach | 16 / 100 | −0,3 / 100 | −3,05 |
| Tianjin Zhongxin Pharmaceutical Group Corp Ltd | 75.9 | Arzneimittel (Pharmazeutisch) | China | 4.6 Mrd. USD | 35.94 | - | 6.46 | 5.13 | ▼ -5.73% | ▲ 26.35% | 11.72% | - | 1 Jahre | 43.34% | ▲ 8.45% | 19.75% | ▲ 3.77% | 6.96% | ▼ -0.21% | 5 / 9 | 5,91 | > 50-fach | 31 / 100 | 14,3 / 100 | −3,15 | |
| Xiamen Amoytop Biotech Co Ltd | 75.9 | Arzneimittel (Biotechnologie) | China | 2.7 Mrd. USD | 21.14 | - | 4.54 | 5.55 | ▲ 36.01% | ▲ 54.85% | 1.48% | - | 2 Jahre | 28.08% | ▲ 3.47% | 33.92% | ▲ 3.17% | 12.81% | ▲ 1.48% | 7 / 9 | 12,13 | > 50-fach | 86 / 100 | 13,0 / 100 | −1,26 | |
![]() | ADMA Biologics Inc | 75.8 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | 15.58 | 22.60 | 5.14 | 6.45 | ▲ 64.60% | - | - | - | - | 28.80% | ▲ 32.38% | 37.53% | ▲ 27.74% | 5.45% | ▲ 39.54% | 5 / 9 | 8,78 | 7-fach | 47 / 100 | 15,5 / 100 | −0,22 |
![]() | Gilead Sciences Inc | 75.3 | Arzneimittel (Biotechnologie) | USA | 197.4 Mrd. USD | - | 15.22 | 6.48 | 16.69 | ▲ 3.58% | ▲ 133.35% | 2.06% | ▲ 2.92% | 10 Jahre | 28.90% | ▼ -0.30% | 39.74% | ▼ -1.42% | 32.12% | ▼ -0.97% | 8 / 9 | 3,37 | 7-fach | 39 / 100 | −2,6 / 100 | −2,45 |
| TTY Biopharm Co Ltd | 74.9 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.6 Mrd. USD | 17.34 | 13.83 | 4.14 | 2.87 | ▲ 8.86% | ▲ 11.03% | 5.62% | - | 3 Jahre | 24.16% | ▲ 1.46% | 26.42% | ▼ -0.08% | 24.97% | ▼ -0.33% | 7 / 9 | 6,58 | 49-fach | 35 / 100 | −1,9 / 100 | −2,33 | |
| Jiangsu Nhwa Pharmaceutical Co Ltd | 74.8 | Arzneimittel (Pharmazeutisch) | China | 3.2 Mrd. USD | 19.57 | - | 3.45 | 2.44 | ▲ 11.95% | ▲ 7.73% | 1.88% | ▲ 31.95% | 2 Jahre | 17.89% | ▼ -0.57% | 19.63% | ▼ -0.77% | 10.84% | ▼ -0.77% | 6 / 9 | 13,97 | > 50-fach | 46 / 100 | −0,2 / 100 | −3,30 | |
![]() | Sectra AB (publ) | 74.7 | Arzneimittel (Pharmazeutisch) | Schweden | 6.6 Mrd. USD | 105.27 | 76.76 | 17.43 | 28.07 | ▲ 16.75% | ▲ 15.40% | 0.38% | - | 1 Jahre | 15.92% | ▲ 0.10% | 18.72% | ▼ -0.60% | 28.57% | ▲ 1.18% | 6 / 9 | 5,24 | > 50-fach | 16 / 100 | −11,9 / 100 | −3,41 |
![]() | Orion Oyj B | 74.5 | Arzneimittel (Pharmazeutisch) | Finnland | 15.4 Mrd. USD | 20.97 | 34.74 | 6.35 | 9.88 | ▲ 11.88% | ▲ 17.87% | 1.88% | - | 3 Jahre | 26.48% | ▲ 1.10% | 33.08% | ▲ 1.36% | 11.60% | ▼ -1.55% | 7 / 9 | 8,48 | > 50-fach | 60 / 100 | 9,1 / 100 | −1,29 |
| Jiangzhong Pharmaceutical Co Ltd | 74.0 | Arzneimittel (Pharmazeutisch) | China | 2.1 Mrd. USD | 16.70 | - | 3.55 | 3.72 | ▲ 11.56% | ▲ 13.85% | 6.29% | ▲ 16.72% | 3 Jahre | 21.47% | ▲ 1.01% | 24.18% | ▲ 0.87% | 16.36% | ▼ -2.42% | 8 / 9 | 6,25 | > 50-fach | 44 / 100 | −1,0 / 100 | −2,80 | |
| Wuhan Keqian Biology Co Ltd | 74.0 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | 16.78 | 113.17 | 6.24 | 1.30 | ▲ 2.42% | ▼ -1.48% | 5.51% | ▲ 17.15% | - | 43.73% | ▼ -1.63% | 50.34% | ▼ -1.92% | 36.27% | ▲ 4.24% | 6 / 9 | 12,62 | > 50-fach | 13 / 100 | −0,2 / 100 | −2,27 |